Find therapies in clinical trials near you – page 185

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Study on Lumasiran for Patients with Advanced Primary Hyperoxaluria Type 1

Study on Lumasiran for Patients with Advanced Primary Hyperoxaluria Type 1

Study on BIA 28-6156 for Parkinson's Disease in Patients with GBA1 Gene Variant

Study on BIA 28-6156 for Parkinson's Disease in Patients with GBA1 Gene Variant

Study on Teicoplanin Dosing for Patients with Sepsis: Comparing TDM-Optimized Dosing to Standard Care

Study on Teicoplanin Dosing for Patients with Sepsis: Comparing TDM-Optimized Dosing to Standard Care

Study on Everolimus and Mycophenolate Mofetil for Improving COVID-19 Vaccine Response in Kidney Transplant Patients

Study on Everolimus and Mycophenolate Mofetil for Improving COVID-19 Vaccine Response in Kidney Transplant Patients

Long-Term Follow-Up Study of Imlifidase in Highly Sensitized Kidney Transplant Patients

Long-Term Follow-Up Study of Imlifidase in Highly Sensitized Kidney Transplant Patients

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Study on PRAX-628 for Epilepsy Patients with Light-Induced EEG Response

Study on PRAX-628 for Epilepsy Patients with Light-Induced EEG Response

Study Comparing DZD9008 and Chemotherapy for First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Mutation

Study Comparing DZD9008 and Chemotherapy for First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Mutation

Study on Personalized Anti-Platelet Therapy with Prasugrel, Clopidogrel, and Ticagrelor for Patients with Stable Coronary Artery Disease Undergoing Stenting

Study on Personalized Anti-Platelet Therapy with Prasugrel, Clopidogrel, and Ticagrelor for Patients with Stable Coronary Artery Disease Undergoing Stenting

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed